These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23254230)

  • 1. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.
    Faseru B; Nollen NL; Mayo MS; Krebill R; Choi WS; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS; Sanderson Cox L
    Addict Behav; 2013 Mar; 38(3):1796-803. PubMed ID: 23254230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
    Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS
    J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion.
    Harris KJ; Okuyemi KS; Catley D; Mayo MS; Ge B; Ahluwalia JS
    Prev Med; 2004 Apr; 38(4):498-502. PubMed ID: 15020185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
    Robles GI; Singh-Franco D; Ghin HL
    Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
    Cox LS; Faseru B; Mayo MS; Krebill R; Snow TS; Bronars CA; Nollen NL; Choi WS; Okuyemi KS; Salzman GA; Benowitz NL; Tyndale RF; Ahluwalia JS
    Trials; 2011 Jan; 12():22. PubMed ID: 21266057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.
    Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS
    JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
    Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
    JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers.
    Thomas JL; Guo H; Lynam IM; Powell JN; Okuyemi KS; Bronars CA; Ahluwalia JS
    J Gen Intern Med; 2008 Sep; 23(9):1361-6. PubMed ID: 18587620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does menthol attenuate the effect of bupropion among African American smokers?
    Okuyemi KS; Ahluwalia JS; Ebersole-Robinson M; Catley D; Mayo MS; Resnicow K
    Addiction; 2003 Oct; 98(10):1387-93. PubMed ID: 14519175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation in smokers who smoke menthol and non-menthol cigarettes.
    Smith SS; Fiore MC; Baker TB
    Addiction; 2014 Dec; 109(12):2107-17. PubMed ID: 24938369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
    JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.
    Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R
    Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
    Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV
    Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
    Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C
    Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of adherence to nicotine gum and counseling among African-American light smokers.
    Okuyemi KS; Zheng H; Guo H; Ahluwalia JS
    J Gen Intern Med; 2010 Sep; 25(9):969-76. PubMed ID: 20495885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.
    Catley D; Harris KJ; Okuyemi KS; Mayo MS; Pankey E; Ahluwalia JS
    Nicotine Tob Res; 2005 Dec; 7(6):859-70. PubMed ID: 16298721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.